FGA Antikörper (Middle Region)

Produktnummer ABIN633846

Der Kaninchen Polyklonal anti-FGA Antikörper (ABIN633846) detektiert spezifisch FGA in WB. Dieser Antikörper reagiert spezifisch mit Proben aus Human.

Kurzübersicht für FGA Antikörper (Middle Region) (ABIN633846)

Target: FGA (Fibrinogen alpha Chain (FGA))

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FGA Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Produktdetails anti-FGA Antikörper

Bindungsspezifität: Middle Region

Spezifität: Fibrinogen Alpha antibody was raised against the middle region of FGA

Aufreinigung: Affinity purified

Immunogen: Fibrinogen Alpha antibody was raised using the middle region of FGA corresponding to a region with amino acids SSSYSKQFTSSTSYNRGDSTFESKSYKMADEAGSEADHEGTHSTKRGHAK

Anwendungsinformationen

Applikationshinweise: WB: 1 µg/mL
Optimal conditions should be determined by the investigator.

Kommentare:

Fibrinogen Alpha Blocking Peptide, (ABIN5613587), is also available for use as a blocking control in assays to test for specificity of this Fibrinogen Alpha antibody

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Lyophilized powder. Add distilled water for a 1 mg/mL concentration of FGA antibody in PBS

Konzentration: Lot specific

Buffer: PBS

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.

Details zu FGA

Target: FGA (Fibrinogen alpha Chain (FGA))

Andere Bezeichnung: Fibrinogen alpha

Hintergrund: FGA is the alpha component of fibrinogen, a blood-borne glycoprotein comprised of three pairs of nonidentical polypeptide chains. Following vascular injury, fibrinogen is cleaved by thrombin to form fibrin which is the most abundant component of blood clots. In addition, various cleavage products of fibrinogen and fibrin regulate cell adhesion and spreading, display vasoconstrictor and chemotactic activities, and are mitogens for several cell types. Mutations in its gene lead to several disorders, including dysfibrinogenemia, hypofibrinogenemia, afibrinogenemia and renal amyloidosis.

Molekulargewicht: 66 kDa (MW of target protein)